Nocturnal urinary melatonin excretion is associated with non-dipper pattern in elderly hypertensives

Hypertension Research

Volumn 36, Issue 8, 2013, Pages 736-740

  Obayashi, Kenji ^a   Saeki, Keigo ^a   Iwamoto, Junko ^b   Okamoto, Nozomi ^a   Tomioka, Kimiko ^a   Nezu, Satoko ^a   Ikada, Yoshito ^a   Kurumatani, Norio ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TENRI HEALTH CARE UNIVERSITY   (Japan)

Author keywords

circadian rhythm; elderly; hypertension; melatonin; non dipper

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; MELATONIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; SLEEP QUALITY; SLEEP TIME; SLEEP WAKING CYCLE; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

ACTIGRAPHY; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MELATONIN; MIDDLE AGED; SLEEP;

EID: 84881399726     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.20     Document Type: Article

References (31)

1. Cuspidi C, Giudici V, Negri F, Sala C, Mancia G. Left ventricular geometry, ambulatory blood pressure and extra-cardiac organ damage in untreated essential hypertension. Blood Press Monit 2010; 15: 124-131.
2. Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Ambulatory blood pressure as an independent determinant of brain atrophy and cognitive function in elderly hypertension. J Hypertens 2008; 26: 1636-1641.
3. Routledge FS, McFetridge-Durdle JA, Dean CRCanadian Hypertension Society. Nighttime blood pressure patterns and target organ damage: a review. Can J Cardiol 2007; 23: 132-138. (Pubitemid 46655428)
4. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 2008; 51: 55-61. (Pubitemid 350307104)
5. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund- Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Wang J, Sandoya E, O'Brien E, Staessen JA. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007; 370: 1219-1229. (Pubitemid 47503300)
6. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001; 38: 852-857. (Pubitemid 34258682)
7. de la Sierra A, Redon J, Banegas JR, Segura J, Parati G, Gorostidi M, de la Cruz JJ, Sobrino J, Llisterri JL, Alonso J, Vinyoles E, Pallarés V, Sarría A, Aranda P, Ruilope LM. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension 2009; 53: 466-472.
8. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20: 2183-2189. (Pubitemid 35388236)
9. Baskett JJ, Cockrem JF, Antunovich TA. Sulphatoxymelatonin excretion in older people: relationship to plasma melatonin and renal function. J Pineal Res 1998; 24: 58-61. (Pubitemid 28161022)
10. Girouard H, Chulak C, Lejossec M, Lamontagne D, de Champlain J. Vasorelaxant effects of the chronic treatment with melatonin on mesenteric artery and aorta of spontaneously hypertensive rats. J Hypertens 2001; 19: 1369-1377. (Pubitemid 32730453)
11. Abete P, Bianco S, Calabrese C, Napoli C, Cacciatore F, Ferrara N, Rengo F. Effects of melatonin in isolated rat papillary muscle. FEBS Lett 1997; 412: 79-85. (Pubitemid 27310004)
12. Arangino S, Cagnacci A, Angiolucci M, Vacca AM, Longu G, Volpe A, Melis GB. Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol 1999; 83: 1417-1419. (Pubitemid 29205758)
13. Scheer FA, Van Montfrans GA, van Someren EJ, Mairuhu G, Buijs RM. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 2004; 43: 192-197. (Pubitemid 38174173)
14. Grossman E, Laudon M, Yalcin R, Zengil H, Peleg E, Sharabi Y, Kamari Y, Shen-Orr Z, Zisapel N. Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am J Med 2006; 119: 898-902. (Pubitemid 44415610)
15. European Medicines Agency, Circadin EPA Report, 2007; available at http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Scientific-Discussion/ human/000695/WC500026808.pdf (accessed on 6 February 2012)
16. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005; 45: 142-161. (Pubitemid 40066429)
17. Takakuwa H, Ise T, Kato T, Izumiya Y, Shimizu K, Yokoyama H, Kobayashi KI. Diurnal variation of hemodynamic indices in non-dipper hypertensive patients. Hypertens Res 2001; 24: 195-201. (Pubitemid 32577139)
18. Middelkoop HA, van Dam EM, Smilde-van den Doel DA, Van Dijk G. 45-hour continuous quintuple-site actimetry: relations between trunk and limb movements and effects of circadian sleep-wake rhythmicity. Psychophysiology 1997; 34: 199-203. (Pubitemid 27143354)
19. Philips Respironics Actiware Tutorials; available at http:// learnactiware.com/tutorials/(accessed on 20 March 2013).
20. Bewick V, Cheek L, Ball J. Statistics review 10: Further nonparametric methods. Crit Care. 2004; 8: 196-199. (Pubitemid 38735700)
21. Brzezinski A. Melatonin in humans. N Engl J Med. 1997; 336: 186-195. (Pubitemid 27034965)
22. Zeman M, Dulková K, Bada V, Herichová I. Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile. Life Sci 2005; 76: 1795-1803. (Pubitemid 40215221)
23. Jonas M, Garfinkel D, Zisapel N, Laudon M, Grossman E. Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. Blood Press 2003; 12: 19-24. (Pubitemid 36416949)
24. 2+ homeostasis in endothelial cells. J Pineal Res 2002; 33: 37-47. (Pubitemid 34833073)
25. Anwar MM, Meki AR, Rahma HH. Inhibitory effects of melatonin on vascular reactivity: possible role of vasoactive mediators. Comp Biochem Physiol C Toxicol Pharmacol 2001; 130: 357-367. (Pubitemid 33043708)
26. K-Laflamme A, Wu L, Foucart S, de Champlain J. Impaired basal sympathetic tone and a1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am J Hypertens 1998; 11: 219-229. (Pubitemid 28137615)
27. Holmes SW, Sugden D. The effect of melatonin on pinealectomy-induced hypertension in the rat. Br J Pharmacol 1976; 56: 360-361.
28. Reiter RJ, Melchiorri D, Sewerynek E, Poeggeler B, Barlow-Walden L, Chuang J, Ortiz GG, Acuña-Castroviejo D. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995; 18: 1-11.
29. Forman JP, Curhan GC, Schernhammer ES. Urinary melatonin and risk of incident hypertension among young women. J Hypertens 2010; 28: 446-451.
30. Pankow W, Nabe B, Lies A, Kohl FV, Lohmann FW. Influence of obstructive sleep apnoea on circadian blood pressure profile. J Sleep Res 1995; 4: 102-106.
31. Mehra R, Stone KL, Ancoli-Israel S, Litwack-Harrison S, Ensrud KE, Redline S. Interpreting wrist actigraphic indices of sleep in epidemiologic studies of the elderly: the Study of Osteoporotic Fractures. Sleep 2008; 31: 1569-1576.